Abstract
Background
The surgery for the treatment of multiple (≥5) bi-lobar hepatic metastases from colorectal cancer is controversial. This retrospective study presents our experience in an attempt to develop reasonable treatment guidelines.
Method
One hundred sixty-one consecutive patients who underwent liver resection with curative intent were classified into three groups: H1 (unilateral), H2 (bilateral, ≤4 nodules), or H3 (bilateral, ≥5 nodules).
Results
The overall cumulative 5-year survival rate was 46.7%. Survival was similar among patients with H1, H2, and H3 disease. Thirty-two patients with H3 disease underwent hepatectomy: straightforward hepatectomy in 12, portal vein embolization (PVE) prior to hepatectomy in eight, two-stage hepatectomy in two, and two-stage hepatectomy combined with PVE in ten. Two-stage hepatectomy with or without PVE was the standard approach in patients with synchronous liver metastases. The operating mortality in hepatectomy for H3 disease was 0%, and the morbidity was 15.2%. The overall response rate to neoadjuvant chemotherapy (NAC) was 41.7% (5/12). Patients who responded to NAC (n=5) had a better prognosis than non-responders (n=7) (P<0.05).
Conclusions
Extended hepatectomy, including preoperative PVE and multi-step hepatectomy, combined with NAC, may result in a favourable prognosis, especially in patients who respond to NAC, but further studies with more patients are needed to confirm this.
Similar content being viewed by others
References
Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T, Yamamoto J, Imamura H (2002) Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer. Long-term results. Ann Surg 231:487–499
Tanaka K, Shimada H, Togo S, Ota M, Yamaguchi S, Ike H (2001) Is hepatic resection for multiple liver metastases from colorectal carcinoma acceptable treatment? Hepatogastroenterology 48:803–807
Nordlinger B, Vaillant JG, Guiguet M, Balladur P, Paris F, Bachellier P, Jaeck D (1994) Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases: Associaion Française de Chirurgie. J Clin Oncol 12:1491–1496
Suzuki S, Sakaguchi T, Yokoi Y, Kurachi K, Okamoto K, Okumura T, Tsuchiya Y, Nakamura T, Konno H, Baba S, Nakamura S (2001) Impact of repeat hepatectomy on recurrent colorectal liver metastases. Surgery 129:421–428
Japanese Society for Cancer of the Colon and Rectum (1997) Japanese classification of colorectal carcinoma, 1st English edn. Kanehara, Tokyo
Ike H, Shimada H, Togo S, Yamaguchi Y, Ichikawa Y, Tanaka K (2002) Sequential resection of lung metastasis following partial hepatectomy for colorectal cancer. Br J Surg 89:1164–1168
Yamanaka N, Okamoto E, Kuwata K, Tanaka N (1984) A multiple regression equation for prediction of posthepatectomy liver failure. Ann Surg 200:658–663
Soyer P, Roche A, Elias D, Levesque M (1992) Hepatic metastases from colorectal cancer: influence of hepatic volumetric analysis on surgical decision-making. Radiology 184:695–697
Elias D, Ouellet JF, de Baere T, Lasser P, Roche A (2002) Preoperative selective portal vein embolization before hepatectomy for liver metastases: long-term results and impact on survival. Surgery 131:294–299
de Baere T, Roche A, Vavasseur D, Therasse E, Indushekar S, Elias D, Bognel C (1993) Portal vein embolization: utility for inducing left hepatic lobe hypertrophy before surgery. Radiology 188:73–77
Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y, Kutsuna Y, Hayakawa N, Yamamoto H (1995) Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. Surgery 117:677–681
Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309–318
Scheele J, Stang R, Altendorf-Hofmann A, Paul M (1995) Resection of colorectal liver metastases. World J Surg 19:59–71
Hughes K, Scheele J, Sugarbaker PH (1989) Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment. Surg Clin North Am 69:339–359
Gayowski TJ, Iwatsuki S, Madariaga JR, Selby R, Todo S, Irish W, Starzl TE (1994) Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 116:703–710
Cady B, Stone MD, McDermott W (1992) Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg 127:561–569
Taylor M, Forster J, Langer B, Taylor BR, Greig PD, Mahut C (1997) A study of prognostic factors for hepatic resection for colorectal metastases. Am J Surg 173:467–471
Wanebo HJ, Chu QD, Veferidis MP, Soderberg C (1996) Patient selection for hepatic resection of colorectal metastases. Arch Surg 131:322–329
Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P (1987) Intrahepatic or systemic infusion of fluorodeoxy uridine in patients with liver metastases from colorectal carcinoma. Ann Intern Med 107:459–465
Chang A, Schneider PD, Sugarbaker PH, Simpson C (1987) A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxy uridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206:685–693
Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A, Lemoine A, Bismuth H (2000) Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 231:480–486
Kawasaki S, Makuuchi M, Kakazu T, Miyagawa S, Takayama T, Kosuge T, Sugihara K, Moriya Y (1994) Resection for multiple metastatic liver tumors after portal embolization. Surgery 115:674–677
Fujii Y, Shimada H, Endo I, Kamiyama M, Kamimukai N, Tanaka K, Kunisaki C, Sekido H, Togo S, Nagashima Y (2000) Changes in clinicopathological findings after portal vein embolization. Hepatogastroenterology 47:1560–1563
Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D, Majno P, Engerran L (1996) Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224:509–522
Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H (2000) Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 232:777–785
Tabuse Y, Tabuse K, Mori K, Nagai Y, Kobayashi Y, Egawa H, Noguchi H, Yamaue H, Katsumi M, Nagasaki Y (1986) Percutaneous microwave tissue coagulation in liver biopsy: experimental and clinical studies. Nippon Geka Hokan 55:381–392
Shibata T, Niinobu T, Ogata N, Takami M (2000) Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer 89:276–284
Seki S, Wakabayashi M, Nakagawa T, Imamura M, Tamai T, Nishimaru A, et al (1999) Percutaneous microwave coagulation therapy for solitary metastatic liver tumors for colorectal cancer: a pilot clinical study. Am J Gastroenterol 94:322–327
Kemmeny N, Huang Y, Cohen AM, Shi W, Conti JA, Brennan MF, Bertino JR, Turnbull AD, Sullivan D, Stockman J, Blumgart LH, Fong Y (1999) Hepatic arterial infusion chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341:2039–2048
Onaitis M, Morse M, Hurwitz H, Cotton P, Tyler D, Clavien P, Clary B (2003) Adjuvant hepatic arterial chemotherapy following metastasectomy in patients with isolated liver metastases. Ann Surg 237:782–789
Kemeny MM, Goldberg D, Beatty JD, Blayney D, Browning S, Doroshow J, Ganteaume L, Hill RL, Kokal WA, Riihimaki DU, et al (1986) Results of prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. Cancer 57:492–498
Giacchetti S, Itzhaki M, Gruia G, Adam R, Zidani R, Kunstlinger F, Brienza S, Alafaci E, Bertheault-Cvitkovic F, Jasmin C, Reynes M, Bismuth H, Misset JL, Levi F (1999) Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 10:663–669
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shimada, H., Tanaka, K., Masui, H. et al. Results of surgical treatment for multiple (≥5 nodules) bi-lobar hepatic metastases from colorectal cancer. Langenbecks Arch Surg 389, 114–121 (2004). https://doi.org/10.1007/s00423-003-0447-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-003-0447-6